China Resources Pharmaceutical Group Limited (HKG: 3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.41
-0.01 (-0.18%)
Nov 15, 2024, 3:40 PM HKT

China Resources Pharmaceutical Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
3,7773,8543,5003,7693,2973,286
Upgrade
Depreciation & Amortization
3,2633,1642,5582,8222,4442,365
Upgrade
Other Amortization
-7.82-----
Upgrade
Loss (Gain) From Sale of Assets
-83.47-63.85-334.84-9.6117.85-1,083
Upgrade
Asset Writedown & Restructuring Costs
1,3351,1611,101265.44678.43774.34
Upgrade
Loss (Gain) From Sale of Investments
46.1321.34-17.41-124.79-107.87-47.68
Upgrade
Loss (Gain) on Equity Investments
-403.86-417.11-332.34-313.6-206.85-140.42
Upgrade
Stock-Based Compensation
116.26141.8999.551.43--
Upgrade
Provision & Write-off of Bad Debts
463.56450.67478.75455.81780.42446.93
Upgrade
Other Operating Activities
5,9685,6364,3695,6775,0664,552
Upgrade
Change in Accounts Receivable
-4,084-6,077-6,441-4,727-5,034-7,805
Upgrade
Change in Inventory
-3,886-2,668-2,233-3,411-805.55-537.47
Upgrade
Change in Accounts Payable
12,02510,9108,1097,5371,5416,190
Upgrade
Change in Unearned Revenue
299.21279.44704.95894.12573.25-282.21
Upgrade
Change in Other Net Operating Assets
-528.43-842.7-741.937.67-37.36422.76
Upgrade
Operating Cash Flow
18,30015,55010,82112,8438,2068,141
Upgrade
Operating Cash Flow Growth
82.03%43.70%-15.74%56.50%0.80%-1.29%
Upgrade
Capital Expenditures
-2,447-2,523-2,279-2,415-1,669-1,649
Upgrade
Sale of Property, Plant & Equipment
213.6176.9573.05143.7194.9491.51
Upgrade
Cash Acquisitions
-1,303---1,737-1,163620.81
Upgrade
Divestitures
39.8539.85422.15234.11946.58185.87
Upgrade
Sale (Purchase) of Intangibles
-574.78-476.91-302.51-601.81-368.31-350.49
Upgrade
Investment in Securities
-5,460-835.49267.68-4,91918.82,345
Upgrade
Other Investing Activities
3,7331,552999.86103.38-168.94-324.84
Upgrade
Investing Cash Flow
-5,797-2,067-819.24-9,191-2,2551,009
Upgrade
Short-Term Debt Issued
--2,3042,5236,97213,471
Upgrade
Long-Term Debt Issued
-85,18488,17591,37955,08656,940
Upgrade
Total Debt Issued
79,40385,18490,47993,90262,05870,411
Upgrade
Short-Term Debt Repaid
--5,213--2,202-8,952-6,698
Upgrade
Long-Term Debt Repaid
--82,426-93,884-85,640-55,978-73,837
Upgrade
Total Debt Repaid
-88,189-87,639-93,884-87,842-64,930-80,535
Upgrade
Net Debt Issued (Repaid)
-8,786-2,455-3,4056,060-2,872-10,124
Upgrade
Repurchase of Common Stock
---3,018--9.52-
Upgrade
Common Dividends Paid
-879.97-879.97-813.07-753.9-691.08-816.99
Upgrade
Other Financing Activities
-2,615-730.22-1,890-2,301-2,842-2,069
Upgrade
Financing Cash Flow
-12,281-4,065-9,1263,005-6,415-13,010
Upgrade
Foreign Exchange Rate Adjustments
6.059.6631.92-362.69-853.81-228.07
Upgrade
Net Cash Flow
227.499,427907.756,294-1,317-4,088
Upgrade
Free Cash Flow
15,85313,0278,54210,4286,5376,492
Upgrade
Free Cash Flow Growth
101.21%52.51%-18.09%59.52%0.69%-3.54%
Upgrade
Free Cash Flow Margin
6.33%5.32%3.91%4.40%3.26%3.18%
Upgrade
Free Cash Flow Per Share
2.522.071.361.661.041.03
Upgrade
Cash Interest Paid
2,5162,6441,9372,6562,8523,615
Upgrade
Cash Income Tax Paid
2,4212,3072,2222,0131,4961,865
Upgrade
Levered Free Cash Flow
1,7701,7658,338-2,987-2,489-25,293
Upgrade
Unlevered Free Cash Flow
3,0903,2429,855-1,293-530.07-22,985
Upgrade
Change in Net Working Capital
4,4833,965-3,6917,2526,77128,568
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.